Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial
Wainberg, Z. A., Shitara, K., Van Cutsem, E., Wyrwicz, L., Lee, K. W., Kudaba, I., . . . Tabernero, J. … Read More
